Oncomine™ Comprehensive Assay Plus GX RNA

The Ion Torrent Oncomine Comprehensive Assay Plus GX RNA is a targeted next-generation sequencing (NGS) assay that provides accurate and sensitive detection of RNA fusion transcripts associated with solid tumors that is appropriate for formalin-fixed paraffin-embedded (FFPE) tissues. This assay is the RNA component of the Oncomine Comprehensive Assay Plus GX (Cat. No. A47013), which includes both DNA and RNA assays.

Key features of the assay include:

• Comprehensive coverage of >1,300 key fusion isoforms from 49 drivers associated with solid tumors
• Provides robust performance from 20 ng of RNA isolated from FFPE samples, including fine needle biopsies
• Provides multiplex sequencing of up to eight RNA-only samples (or eight plus optional NTC) per GX7 Chip lane
• System-installed assays preconfigured with settings optimized for specific applications and sample types
• Requires as little as 10 minutes hands-on time per run for easy, automated workflows
• Provides automated Nucleic Acid to Result workflow on the Genexus Integrated Sequencer with next-day results

When used with the Genexus Purification System and the Genexus Integrated Sequencer, sequential sample purification, library preparation, sequencing, and analysis allow for the reporting of next-day results. With just two user touchpoints and as little as 20 minutes of hands-on time, the easy, automated workflows can help reduce handling errors, free up time for your laboratory staff, and reduce labor costs. As a single vendor of sample-to-report solutions, including instruments, consumables, analysis, and support, Thermo Fisher Scientific simplifies bringing in-house genomic profiling to your lab at varying levels of NGS expertise.